cyclohexanol has been researched along with Diabetes Mellitus, Type 1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, BL; Friedman, GC; Lim, AK; Ma, FY; Nikolic-Paterson, DJ; Ozols, E; Tesch, GH; Young, MJ | 1 |
Arguisola, MS; Tavakoli, SA | 1 |
Lithner, F | 1 |
3 other study(ies) available for cyclohexanol and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
Topics: Albuminuria; Animals; Blood Pressure; Body Weight; Cyclohexanols; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Early Medical Intervention; Hypertension; Hypertrophy; Immunohistochemistry; Inhibitory Concentration 50; Male; MAP Kinase Kinase 4; Protein Kinase Inhibitors; Purines; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction | 2011 |
Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Interactions; Drug Therapy, Combination; Humans; Male; Obesity; Olanzapine; Pirenzepine; Risk Factors; Valproic Acid; Venlafaxine Hydrochloride | 2003 |
Venlafaxine in treatment of severe painful peripheral diabetic neuropathy.
Topics: Adult; Cyclohexanols; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |